Breast Screening
8
1
3
4
Key Insights
Highlights
Success Rate
80% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 49/100
12.5%
1 terminated out of 8 trials
80.0%
-6.5% vs benchmark
13%
1 trials in Phase 3/4
50%
2 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (8)
Digital Tomosynthesis Mammography and Digital Mammography in Screening Patients for Breast Cancer
Prospective Case Collection Study of Contrast-Enhanced Mammography Imaging Acquired on a New Investigational Device
My Personalized Breast Screening
Study of iBreast, a Handheld Device to Detect Breast Abnormalities During Screening Visits for Breast Cancer
Novel MRI Sequence MR Fingerprinting in Breast MRI Feasibility Study
Clinical Utility of Whole Breast Screening Ultrasound in Patients Undergoing Digital Breast Tomosynthesis
Can Contrast-Enhanced Spectral Mammography Improve the Accuracy of a Diagnosis
Are Text Message Reminders an Effective Intervention for Improving the Uptake of Breast Screening?